CMS Reimbursement-Ready
Diabetes &
Chronic Care
Programs®
Screen. Test. Treat.
"We help clinics use non-invasive and reimbursable tests, supported by trained technicians."
-Daniel Medrano
Founder & CEO
Embedded Files
🔥 NEW Wireless Neuropathy Tool—100% Tax Deductible.
Exclusively for Healthcare Providers
Exclusively for Healthcare Providers
The price of late detection
The price of late detection
The first year after a major diabetic complication carries a significantly increased mortality risk:
Up to 50% for Alzheimer's.
Up to 40% for amputations.
Up to 30% for strokes.
These aren’t numbers, they’re hearts with families.
Find what others miss
Diabetes Testing Centers™ (DTC), was founded by former family practice owners who saw the consequences of late detection, missed reimbursements, and preventable complications in everyday care. With a national provider network of over 20,000 outpatient clinics, our mission is to close these gaps by equipping providers with non-invasive, reimbursable, point-of-care tests, supported by trained technicians—to identify early risks and address them in the same visit, streamlining care and reducing unnecessary referrals.
Chronic conditions don’t have to be deadly.
DTC works to identify silent, preventable conditions before they become life-threatening. From heart and nerve health to cognitive and vascular function, our suite of quick, non-invasive assessments delivers real-time data at the point of care—empowering providers to detect risk and intervene early. By uncovering complications in their earliest stages, DTC helps clinics manage chronic diseases proactively, improve outcomes, and ultimately save lives.
Pick A pathway
ACO | Concierge | Functional | Private | Regenerative
Designed for both insurance-based and cash-based medical practices that prioritize early detection, personalized care, and measurable clinical outcomes.
Add reimbursable therapies to your existing assessments, instead of referring them out.
Early Detection Matters
Early Detection Matters
Early Detection Gives Families More Time and Memories to Share.
Early Testing Matters
Early Testing Matters
Diabetes Testing Centers™ (DTC) helps both new and established medical providers unlock the full clinical and financial potential of early detection screening for diabetes patients. We go beyond routine glucose checks by offering CMS billable assessments and point-of-care reimbursable diagnostics that are faster, more impactful, and fully reimbursable. DTC transforms routine exams—including Annual Wellness Visits—into advanced preventive care encounters by combining reimbursable diagnostics, state-of-the-art early-detection technology, and chronic-care pathways that ensure compliance and payment integrity.
Note: Each test is based on medical necessity for early detection, requires an average of three minutes or less to administer, and targets the complications most likely to affect patients with diabetes.
Quick Assessment Examples
Heart Disease: Cardiovascular disease is the leading cause of death in the United States, responsible for approximately 1 in every 5 deaths (Center for Disease Control & Prevention). For individuals with diabetes, the risk is up to 4 times higher than for those without diabetes, with earlier onset, faster progression, and higher mortality.
Diabetic Peripheral Neuropathy (DPN): Studies estimate that up to 50% of patients with diabetes will develop some form of neuropathy during their lifetime. Small-fiber damage is often the first, years before large-fiber involvement and can precede other microvascular complications like retinopathy and nephropathy (American Diabetes Association, Diabetes Care).
Cognitive Dysfunction: Alzheimer’s disease is fatal because it progressively damages the brain’s ability to control vital functions such as swallowing, breathing, and heart regulation, ultimately leading to death. Neurological impairment is recognized as a diabetes complication, with evidence suggesting cognitive decline occur simultaneously with neuropathy. (Kodl & Seaquist, Nature Reviews Endocrinology).
Psychological Disorders: Depression and anxiety are highly prevalent in patients with painful diabetic neuropathy. Published studies in Diabetes Care, Pain, and the Journal of Neurology, Neurosurgery & Psychiatry report rates as high as 60%. These comorbidities complicate self-management, worsen outcomes, and increase overall healthcare utilization.
Our exclusive 25 turnkey Diabetes & Chronic Care Programs® are designed for primary care and multispecialty settings and chronic patients. Built on the same protocols and equipment trusted by national specialty centers, each compact program can operate in a single room and deliver CMS reimbursement-ready programs—many of which do not require new staff, new construction, or disruption to your workflow.
By partnering with DTC, providers can screen smarter, intervene earlier, and transform routine checkups into life-saving opportunities—while building sustainable new revenue streams that strengthen their practice long-term.
Reduced Workflows. Better Diagnostics.
Following National Guidelines
National guidelines recommend that primary care physicians, endocrinologists, podiatrists, and neuropathy specialists screen all diabetic patients for neuropathy at least once a year. Neuropathy is one of the earliest and most common complications of diabetes, and its detection has important clinical implications.
Small fiber neuropathy is often the first sign of metabolic dysfunction or poorly controlled diabetes, serving as an early warning that systemic complications may be developing.
Large fiber neuropathy, on the other hand, is closely tied to loss of protective sensation—leading to falls, infections, wounds, and ultimately amputations and inspected at every visit once identified.
When neuropathy is detected, it not only signals nerve damage but also indicates an elevated risk of other serious diabetes-related complications such as cardiovascular disease, renal decline, and vision loss, all of which share the same underlying metabolic origin. When you can Screen, Test and Treat in-house and remotely, you not only keep patients under your care, you break the chain reaction at its source. That’s what makes our Chronic Care Programs® more than just assessments, they are the bridge between routine care and long-term health.
Neuropathy is a serious condition that, if not accurately diagnosed and treated promptly, can lead to devastating outcomes, such as amputations of the toes, feet, or legs. The failure to adopt advanced diagnostic tools and procedures has resulted in medical institutions and physicians being held liable for malpractice. A landmark case, Washington v. Washington Hospital (1990)., set legal precedent in the U.S. regarding this issue.
About 80% of 65+ have two or more chronic conditions.
Testing Before Referring
Testing Before Referring
Reimbursable diagnostics
Reimbursable diagnostics
Most diabetic and chronic patients don't always see the specialists who could detect early complications because referrals are delayed, so the urgency is slowed and the disease progresses silently. The difference isn’t necessarily the visit itself—it’s the results of the diagnostic tools that help determine the plan of care for the patients. Traditional screening tools in PCP clinics are often outdated, limited in what they detect and non-reimbursable (e.g. monofilaments). DTC brings modern, clinically validated, reimbursable diagnostics into a practice, enabling primary care and multispecialty clinics to identify risks earlier and keep care in-house—before referrals are needed. Better detection. Better outcomes. Better Revenue.
Our Diabetes & Chronic Care Programs® give providers a simple yet powerful way to intervene at this gateway. Through CMS billable assessments, reimbursable diagnostics, and early detection screenings, we help close care gaps while building new revenue streams. Instead of relying on outdated tools (e.g., fishing string for foot exams), replace them with modern, non-invasive diagnostic devices that are reimbursable and fit directly into existing workflows. The visit stays the same—the tools simply get better, the data becomes clearer, and the clinic is reimbursed for the care it is already providing.
Nearly 80% of people with diabetes will develop one or more complications over time, while only a small minority remain unaffected. Most patients are silently progressing toward cardiovascular disease, kidney damage, retinopathy, and preventable amputations. By the time many of these are discovered, the damage is often advanced, requiring costly specialist care and creating long-term burdens for patients and payers alike.
Our turnkey programs make it possible to intervene earlier with rapid, non-invasive, point-of-care tools such as neuropathy testing, PAD screening, cognitive assessments, and cardiovascular risk evaluations. Each fits seamlessly into your workflow, enabling your team to detect risks, initiate treatment plans, and manage progression both in-clinic and remotely. The result is better outcomes for patients, stronger trust in your care, and new reimbursable revenue streams that support practice growth.
Primary Care
Neurology
Cardiology & Vascular
Endocrinology & Metabolism
Podiatry & Wound Care
Functional & Regenerative*
Why Offer In-House Specialty Testing
Most diabetic patients never see the specialists who could detect early complications—referrals are delayed, visits are missed, and disease progresses silently. Primary care and multispecialty clinics are best positioned to catch problems early with in-office testing. Diabetes Testing Centers™ (DTC) makes this easy by integrating into one exam room and providing up to 25 reimbursable assessments for neuropathy, vascular, cognitive, metabolic risks, and more. This turnkey model helps clinics improve outcomes, retain revenue, and deliver specialty-level care where patients already are.
Upgrade to Reimbursable Tools
More Than Glucose
More Than Glucose
Primary Care Providers (PCP) check patients blood glucose but why stop there? With in-clinic neuropathy, cognitive, or vascular testing, you can diagnose earlier, act sooner, and keep care under your roof instead of waiting on outside referrals. This means you’re not just monitoring—you’re diagnosing, acting sooner, and keeping patients under your care with clinically valuable results that directly improve outcomes.
Getting Started Is Simple:
1. Identify Your Top 3 Referrals
1. Identify Your Top 3 Referrals
Think about the top three patient referrals your clinic makes, like labs, neurology, podiatry, endocrinology, cardiology, physical therapy, or others. This helps you determine which patients have unmet needs that your clinic may fulfill.
Review our Chronic Care Programs® and pick one that aligns with the referrals you make. For example, if you refer patients to neurology, choose our neuropathy testing program. If you refer to cardiology, consider our cardiovascular risk evaluation, etc.
3. Schedule a Meeting Below to Get Started
3. Schedule a Meeting Below to Get Started
Select a program with a zero-down option to begin testing these patients immediately in your clinic, without any upfront investment and get a financial pro forma from us based on your location and payor reimbursements. This allows you to start providing and billing for these services, regularly in 30 days or less.
Your Next Referral Could Be A Missed Diagnosis
Schedule Below to Learn More
Schedule Below to Learn More
"Book a 15‑minute walkthrough” to see how easily DTC programs integrate into your existing workflows.
Test Before You Refer
Test Before You Refer
Page updated
Report abuse